Press "Enter" to skip to content

Covid-19 has highlighted the Indian pharma industry’s potential in transforming into an innovation hub: Sudarshan Jain

​Taking learning from the second wave, the industry is preparing proactively and intends to be ahead in terms of drug availability and facilitating collaboration across stakeholders.

Original source: https://health.economictimes.indiatimes.com/news/pharma/83608836?utm_source=RSS&utm_medium=ETRSS